Tyra Biosciences (TYRA) Stock Forecast & Price Target

$15.87 -0.34 (-2.10%)

(As of 11/20/2024 ET)

Tyra Biosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 5 Analyst Ratings

Sell
0

Hold
0

Buy
5

Based on 5 Wall Street analysts who have issued ratings for Tyra Biosciences in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 5 have given a buy rating for TYRA.

Consensus Price Target

$31.00
95.34% Upside

According to the 5 analysts' twelve-month price targets for Tyra Biosciences, the average price target is $31.00. The highest price target for TYRA is $33.00, while the lowest price target for TYRA is $28.00. The average price target represents a forecasted upside of 95.34% from the current price of $15.87.

Get the Latest News and Ratings for TYRA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Tyra Biosciences and its competitors.

TYRA Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$31.00	$31.00	$24.80	$23.67
Forecasted Upside	95.34% Upside	10.09% Upside	12.42% Upside	107.42% Upside
Consensus Rating	Buy	Buy	Moderate Buy	Buy

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

TYRA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TYRA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tyra Biosciences Stock vs. The Competition

Type	Tyra Biosciences	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	95.34% Upside	26,906.43% Upside	9.81% Upside
News Sentiment Rating	Neutral News See Recent TYRA News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/11/2024	HC Wainwright 2 of 5 stars		Lower Target	Buy ➝ Buy	$32.00 ➝ $30.00	+91.33%
10/25/2024	Wedbush 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$28.00 ➝ $28.00	+19.66%
10/18/2024	Bank of America 4 of 5 stars		Upgrade	Neutral ➝ Buy	$22.00 ➝ $31.00	+19.32%
9/19/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$25.00 ➝ $33.00	+42.24%
8/15/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Raymond Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$33.00	+52.99%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:11 AM ET.

TYRA Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Tyra Biosciences is $31.00, with a high forecast of $33.00 and a low forecast of $28.00.
: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tyra Biosciences in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TYRA shares.
: According to analysts, Tyra Biosciences's stock has a predicted upside of 95.34% based on their 12-month stock forecasts.
: Over the previous 90 days, Tyra Biosciences's stock had 1 upgrade by analysts.
: Tyra Biosciences has been rated by research analysts at Bank of America, HC Wainwright, Oppenheimer, and Wedbush in the past 90 days.
: Analysts like Tyra Biosciences more than other "medical" companies. The consensus rating for Tyra Biosciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TYRA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!

This page (NASDAQ:TYRA) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tyra Biosciences (TYRA) Stock Forecast & Price Target